IMFINZI (Durvalumab)

**Product type:** Human Prescription Drug

**Active ingredient:** DURVALUMAB

**Strength:** 120 mg/2.4mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** AstraZeneca Pharmaceuticals LP

**Marketing category:** BLA (BLA761069)

**Pharmacologic class:** Antibodies, Monoclonal [CS], Programmed Death Ligand-1 Antagonists [MoA], Programmed Death Ligand-1 Blocker [EPC], Programmed Death Ligand-1-directed Antibody Interactions [MoA]